Kramer Levin Receives M&A Advisor’s Corporate and Strategic Deal of the Year
New SEC Guidance on Five-Business-Day Tender Offers and Exchange Offers
Marcus A. Colucci represents clients in complex patent and general commercial litigation in courts across the country, as well as in the licensing of intellectual property rights.
Mr. Colucci represents both patent owners seeking to enforce their rights and companies defending against allegations of patent infringement. He has litigated disputes related to a diverse array of technologies, including pharmaceuticals, medical devices, nutraceuticals, telecommunication systems, smartphones, network security systems, satellite radio systems and GPS navigation systems.
Mr. Colucci has firsthand experience in all aspects of litigation, including jury trials, bench trials, oral argument, the taking and defense of fact and expert depositions, the preparation of dispositive motions, patent claim construction, case management, discovery, settlement negotiations and licensing. His litigation work includes actions in the District of New Jersey, District of Delaware, Eastern District of Texas, Eastern District of Virginia, Eastern and Southern Districts of New York, District of Nebraska, District of Arkansas, and the Court of Appeals for the Federal Circuit.
Most recently, Mr. Colucci was a member of a trial team that obtained a jury award of $30 million against a major telecommunications company in a patent dispute involving access control for wireless network infrastructure and a favorable settlement against another major telecommunications company after a seven-day trial. He also was a member of the trial team representing Merck in a bench trial against Xellia Pharmaceuticals, obtaining a judgment of infringement of a patent covering the antifungal drug Cancidas®.
Mr. Colucci advises clients on managing and monetizing patent portfolios, including the acquisition and sale of patents, as well as on infringement, validity and freedom to operate matters.